Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $2000.0.

  • Arcadia Biosciences' Depreciation & Amortization (CF) fell 7142.86% to $2000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4000.0, marking a year-over-year increase of 9024.39%. This contributed to the annual value of $58000.0 for FY2024, which is 4774.77% down from last year.
  • Per Arcadia Biosciences' latest filing, its Depreciation & Amortization (CF) stood at $2000.0 for Q3 2025, which was down 7142.86% from $15000.0 recorded in Q2 2025.
  • In the past 5 years, Arcadia Biosciences' Depreciation & Amortization (CF) registered a high of $253000.0 during Q3 2021, and its lowest value of -$116000.0 during Q4 2023.
  • Its 5-year average for Depreciation & Amortization (CF) is $79578.9, with a median of $71000.0 in 2023.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first soared by 21891.89% in 2021, then tumbled by 23647.06% in 2023.
  • Arcadia Biosciences' Depreciation & Amortization (CF) (Quarter) stood at $192000.0 in 2021, then crashed by 55.73% to $85000.0 in 2022, then plummeted by 236.47% to -$116000.0 in 2023, then surged by 70.69% to -$34000.0 in 2024, then surged by 105.88% to $2000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $2000.0 in Q3 2025, compared to $15000.0 in Q2 2025 and $13000.0 in Q1 2025.